Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soft tissue sarcomas.

Janice N Cormier1, Raphael E Pollock

  • 1Department of Surgical Oncology and Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

CA: a Cancer Journal for Clinicians
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Variability in Extracellular Vesicle Characterization Across Measurement Techniques.

Journal of extracellular biology·2026
Same author

Notch signaling regulates the secretion of pro-metastatic factors in extracellular vesicles in liposarcoma.

Cancer letters·2026
Same author

Blockade of interleukin-6 (IL-6) signaling in dedifferentiated liposarcoma (DDLPS) decreases mouse double minute 2 (MDM2) oncogenicity via alternative splicing.

PloS one·2025
Same author

Oncogenic Functions of Alternatively Spliced <i>MDM2-ALT2</i> Isoform in Retroperitoneal Liposarcoma.

International journal of molecular sciences·2025
Same author

Three-dimensional models: from cell culture to Patient-Derived Organoid and its application to future liposarcoma research.

Oncology research·2024
Same author

Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling.

Frontiers in oncology·2024
Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026
Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026
Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026
Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026
Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026
See all related articles

Soft tissue sarcomas are rare cancers originating from mesoderm. Despite advances, metastasis remains a challenge, but molecular research promises future targeted therapies.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Sarcomas are rare, heterogeneous tumors originating from embryonic mesoderm.
  • They often present as asymptomatic masses, commonly in extremities, but can occur elsewhere.
  • Accurate diagnosis and staging are crucial for effective treatment planning.

Purpose of the Study:

  • To review the diagnostic and staging modalities for soft tissue sarcomas.
  • To discuss current treatment strategies and their limitations.
  • To highlight the potential of molecular advancements in future therapies.

Main Methods:

  • Review of radiologic imaging techniques for sarcoma assessment.
  • Discussion of core-needle biopsy as the preferred diagnostic method.

Related Experiment Videos

  • Analysis of the American Joint Committee on Cancer (AJCC) staging system.
  • Main Results:

    • Pretreatment imaging is vital for local extent definition, staging, and biopsy guidance.
    • Core-needle biopsy is the gold standard for soft tissue sarcoma diagnosis.
    • The AJCC staging system incorporates grade, size, depth, and metastasis.
    • Despite improved local control, metastasis occurs in 50% of high-risk cases, primarily to the lungs.

    Conclusions:

    • Effective management of soft tissue sarcomas relies on accurate imaging and biopsy.
    • Metastasis remains a significant challenge, particularly in high-risk tumors.
    • Future molecular insights are expected to drive the development of novel, targeted therapies.